Medtronic (NYSE:MDT) said today that it enrolled the 1st European patient in a huge, real-world study of the SuperDimension lung device it acquired along with Covidien early last year. The 2-year, 2,500-patient Navigate trial is designed to evaluate the performance of the LungGPS electromagnetic navigation bronchoscopy technology the SuperDimension device uses to navigate the lungs. The single-arm post-market study […]
Pulmonary
Veran Medical pulls in $31m for lung nav device
Veran Medical Technologies said today that it raised a $30.6 million funding round, led by Versant Ventures and River Cities Capital Funds, that it plans to use to expand the commercial footprint of its lung navigation platform. St. Louis-based Veran said prior backers Prolog Ventures, Advantage Capital, Rex Health Ventures, 3G Capital, Dynamic Investments and Vectis also joined the […]
Medtronic launches real-world study for SuperDimension lung device
Medtronic (NYSE:MDT) said today that it launched a huge, real-world study of the SuperDimension lung device it acquired along with Covidien earlier this year. The 2-year, 2,500-patient Navigate trial is designed to evaluate the performance of the LungGPS electromagnetic navigation bronchoscopy technology the SuperDimension device uses to navigate the lungs. The single-arm, multi-center post-market observational study […]
Sanovas wins FDA 510(k) clearance for PulmoVia
Sanovas said last week that it won FDA 510(k) clearance for its PulmoVia working channel, part of its platform designed to improve diagnostic and therapeutic interventions in the lung. Working channels are normally integrated into bronchoscopes with optics as 1 piece, but the PulmoVia working channel is separate, CEO Larry Gerrans told MassDevice.com. “We took a […]
BTG to buy PneumRx for up to $475m
Medicare OKs coverage of high-risk CT lung screening
Covidien unveils next-gen superDimension device
Veran raises nearly $3M for 3d airway mapping system
Veran Medical Technologies said it brought in $2.9 million in a funding round it hopes will eventually add $5 million to its coffers.
The St. Louis-based medical device company, founded in 2005, is developing devices for diagnosis & minimally invasive surgery.
Rumor: Stryker to pay $30M for ActiViews
Sanovas raises $6.5M Series A1 round
Sanovas raised $6.5 million in a Series A1 round co-founder & CEO Larry Gerrans told MassDevice.com will go toward commercializing its Vas Zeppelin pulmonary device.
Sausalito, Calif.-based Sanovas closed a Series A round last summer consisting entirely of friends and family, Gerrans told us.